|
LRRC59 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.60920055058966E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.20340000040609E-07 |
| Normal-vs-Stage2 |
1.099730E-02 |
| Normal-vs-Stage3 |
1.613020E-04 |
| Normal-vs-Stage4 |
3.077800E-02 |
| Stage1-vs-Stage2 |
8.755800E-01 |
| Stage1-vs-Stage3 |
2.699700E-02 |
| Stage1-vs-Stage4 |
1.743560E-01 |
| Stage2-vs-Stage3 |
7.107600E-02 |
| Stage2-vs-Stage4 |
2.095400E-01 |
| Stage3-vs-Stage4 |
8.394000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.24659982126252E-10 |
| Normal-vs-AfricanAmerican |
6.10289999999347E-05 |
| Normal-vs-Asian |
1.989640E-01 |
| Caucasian-vs-AfricanAmerican |
1.045650E-01 |
| Caucasian-vs-Asian |
5.278600E-01 |
| AfricanAmerican-vs-Asian |
4.090200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.48869999847679E-08 |
| Normal-vs-Female |
7.62800045350787E-10 |
| Male-vs-Female |
1.542700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.577200E-03 |
| Normal-vs-Extreme_Weight |
1.54685000000043E-05 |
| Normal-vs-Obese |
2.6446999999985E-06 |
| Normal-vs-Extreme_Obese |
1.863450E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.017400E-01 |
| Normal_Weight-vs-Obese |
7.081200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.888200E-01 |
| Extreme_Weight-vs-Obese |
3.819400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.522400E-01 |
| Obese-vs-Extreme_Obese |
3.443200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.787300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.93099980450029E-10 |
| Normal-vs-Age(61-80Yrs) |
1.71437999999524E-05 |
| Normal-vs-Age(81-100Yrs) |
3.398400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.802200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.779800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.231000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.795700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.620200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.831820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.95909999947774E-07 |
| Normal-VS-Type2 PRCC |
1.53612000000081E-05 |
| Normal-VS-KIRP CIMP |
1.321550E-03 |
| Normal-VS-Unclassified PRCC |
2.05409999998185E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.158210E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.542200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.935900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.363800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.230000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.977100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.153830E-04 |
| Normal-vs-N1 |
1.404820E-04 |
| Normal-vs-N2 |
1.631570E-01 |
| N0-vs-N1 |
3.108000E-02 |
| N0-vs-N2 |
3.077200E-01 |
| N1-vs-N2 |
3.831000E-01 |
|
|
